Converge Bio vs Queen Mary University of London Spinouts
Converge Bio vs Queen Mary University of London Spinouts, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Converge Bio is on 56/100 and Queen Mary University of London Spinouts on 7/100.
Where each one leads
Converge Bio
- our overall score: 56/100 against 7/100
- agent readiness: 44/100 against 25/100
Queen Mary University of London Spinouts
- domain rating: 84/100 against 29/100
At a glance
| Measure | Converge Bio | Queen Mary University of London Spinouts |
|---|---|---|
| What it is | Computational platform using LLMs trained on biological and chemical data for drug discovery. | A collective of grant-stage to Series A companies spun out from Queen Mary University of London, actively seeking investment in sectors like life sciences, AI, and sustainability. |
| Category | Life Sciences, Generative AI, Large Language Models (LLMs), Pharmaceutical | Life Sciences, Sustainability, University Spinout, Technology Transfer |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2023 | Not published |
| Headquarters | San Francisco, United States | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Converge Bio | Queen Mary University of London Spinouts |
|---|---|---|
| Employees | 51 | Not published |
| Headcount growthLast 12 months | +220.3% | Not published |
| Total funding | $5.5M | Not published |
| Latest round | Seed | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 6,830 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Converge Bio | Queen Mary University of London Spinouts |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 7/100 |
| Traction | 51/100 | Not published |
| Team | 70/100 | Not published |
| Search visibility | 36/100 | Not published |
| Quality | 62/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (25/100) |
| Domain ratingLink authority, 0-100 | 29/100 | 84/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Converge Bio | Queen Mary University of London Spinouts |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Not detected | CloudFront |
| CMS | Framer | Not detected |
| Frameworks | Not detected | Jquery, Tailwind CSS |
| Analytics | Google Tag Manager, Microsoft Clarity | Google Tag Manager, Linkedin Insight |
| Support stack | HubSpot | Not detected |
| Open source | Yes | No |
| Self-hostable | Yes | No |
Converge Bio vs Queen Mary University of London Spinouts: common questions
Which is better, Converge Bio or Queen Mary University of London Spinouts?
On our 0-100 score Converge Bio rates higher (56/100 against 7/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Converge Bio and Queen Mary University of London Spinouts compare on the numbers?
Converge Bio leads on our overall score (56/100 against 7/100), agent readiness (44/100 against 25/100). Queen Mary University of London Spinouts leads on domain rating (84/100 against 29/100).
Read the full Converge Bio review and pricing or the Queen Mary University of London Spinouts review and pricing. You can also browse other Converge Bio alternatives we track.